NCT04013035

Brief Summary

Cervical length is used as a parameter to predict cervical insufficiency and onset of labor. However, its role in predicting abortion induction is unclear.To investigate the impact of cervical length measurement and fetal viability on second trimester pregnancy termination duration in nulliparous pregnant women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

July 7, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 9, 2019

Completed
Last Updated

July 10, 2019

Status Verified

July 1, 2019

Enrollment Period

1.4 years

First QC Date

July 7, 2019

Last Update Submit

July 8, 2019

Conditions

Pregnancy Loss

Keywords

CervixLengthViabilityprostaglandinTermination

Outcome Measures

Primary Outcomes (1)

  • cervical length measurement

    cervical length measurement at second trimester pregnancy termination in nulliparous pregnant women. The measurements will be saved as a number in cm.

    2 days

Interventions

cervical length measurementPROCEDURE

cervical length measurement at second trimester pregnancy termination in nulliparous pregnant women.

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Nulliparous pregnant women at 13-26 weeks of gestation will be included in the study.

You may qualify if:

  • Nulliparous pregnant women at 13-26 weeks of gestation

You may not qualify if:

  • Patients with multiple gestations,
  • multiparous patients or
  • patients that had uterine gynecologic surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kanuni Sultan Süleyman Training and Research Hospital

Istanbul, 33404, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator, M.D, Department of Obstetrics and Gynecology

Study Record Dates

First Submitted

July 7, 2019

First Posted

July 9, 2019

Study Start

January 1, 2016

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

July 10, 2019

Record last verified: 2019-07

Locations

TU(1)